Classement en actions
#33746
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Prix de l'action
$0.4523
Dernière synchronisation: 2023-03-03
Capitalisation boursière
$6.97M
Changement (1 jour)
-19.23%
Échange Lucira Health, Inc. (LHDX)
Le prix LHDX avec la capitalisation boursière de B
Capitalisation boursière de Lucira Health, Inc.(LHDX)
Capitalisation boursière: $6.97M
En August 2026, Lucira Health, Inc. a une capitalisation boursière de $6.97M. Cela fait de Lucira Health, Inc. la 33746th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Lucira Health, Inc. du 2021 au 2026
LHDX par rapport au top 5 des plus populaires stocks
| Prix pour LHDX |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.452T
|
+78,259,697.47%
|
|
|
|
|
$4.490T
|
+64,452,686.87%
|
|
|
|
|
$4.162T
|
+59,749,906.09%
|
|
|
|
|
$3.676T
|
+52,772,606.31%
|
|
|
|
|
$2.833T
|
+40,667,310.32%
|
